Investing.comCodex · 实盘不做把握 8/10
北京时间·🕒 发布 20:12:31时区推断·⟳ 抓取 20:14:54·⚡ 决策 07-22 20:21:40 +6m46s·97.0 天前
Inspire Medical董事Tansey将于7月30日退休
董事退休属于常规治理变动，未披露经营、订单、监管或财务增量。
📄 原文Investing.com↗ 原文
Inspire Medical board member Tansey to retire July 30
Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven? MINNEAPOLIS - Inspire Medical Systems Inc…
不做 Inspire Medical Systems（INSP.US）
董事退休不涉及经营、订单、业绩或监管增量，无法形成同向事件交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 low · price-in 风险 low ↗
关键理由
- 董事退休属于常规治理变动，未披露经营、订单、监管或财务增量。
主要风险
- 不构成短周期可交易催化。
原文全文
展开原文 · 1,350 字
Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
MINNEAPOLIS - Inspire Medical Systems Inc. (NYSE:INSP) announced that Casey M. Tansey will retire from its board of directors effective July 30 after more than 18 years of service, according to a press release statement.
Tansey represented U.S. Venture Partners and led Inspire’s Series A financing in November 2007. He has served on the board since that time.
"We are thankful for the many contributions Mr. Tansey has made to our Board of Directors over the past eighteen years," said Tim Herbert, chairman and chief executive officer of Inspire Medical Systems. Herbert noted that Tansey was among the first venture investors to recognize the company’s potential and provided mentorship and leadership through the company’s founding, initial public offering and subsequent growth.
The company stated it expects to announce the appointment of a new director to replace Tansey in the near future.
Inspire Medical Systems is a medical technology company focused on obstructive sleep apnea solutions. The company develops Inspire therapy, a neurostimulation technology approved by the FDA, EU MDR and PDMA for treating moderate to severe obstructive sleep apnea.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
MINNEAPOLIS - Inspire Medical Systems Inc. (NYSE:INSP) announced that Casey M. Tansey will retire from its board of directors effective July 30 after more than 18 years of service, according to a press release statement.
Tansey represented U.S. Venture Partners and led Inspire’s Series A financing in November 2007. He has served on the board since that time.
"We are thankful for the many contributions Mr. Tansey has made to our Board of Directors over the past eighteen years," said Tim Herbert, chairman and chief executive officer of Inspire Medical Systems. Herbert noted that Tansey was among the first venture investors to recognize the company’s potential and provided mentorship and leadership through the company’s founding, initial public offering and subsequent growth.
The company stated it expects to announce the appointment of a new director to replace Tansey in the near future.
Inspire Medical Systems is a medical technology company focused on obstructive sleep apnea solutions. The company develops Inspire therapy, a neurostimulation technology approved by the FDA, EU MDR and PDMA for treating moderate to severe obstructive sleep apnea.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。